Wall Street expected President Donald Trump to go easier on Medicare Advantage insurers than his predecessor. That's not ...

Four medical professionals with the nonprofit Doctors for America write that Dr. Mehmet Oz's conflicts of interest and support of therapies not grounded in science make him a poor choice ...

Adopting this approach, CMS could make achieving a certain threshold of successful treatment of hypertension the dominant ...